File:Fimmu-11-603312-g001.jpg
Jump to navigation
Jump to search
No higher resolution available.
Fimmu-11-603312-g001.jpg (793 × 555 pixels, file size: 146 KB, MIME type: image/jpeg)
Captions
Captions
asthma
Summary
[edit]
| Description |
English: Molecular targets of current and future biological therapies of severe type 2 asthma. The targets of approved add-on biologic treatments (highlighted in blue color) of severe asthma include IgE (omalizumab), IL-5 (mepolizumab and reslizumab), IL-5 receptor (benralizumab), and IL-4/IL-13 receptor complex (dupilumab). Moreover, experimental drugs (highlighted in dark magenta color) such as tezepelumab, REGN3500 and fevipiprant target TSLP, IL-33 and the CRTH2 receptor of PGD2, respectively. |
| Date | |
| Source | https://pubmed.ncbi.nlm.nih.gov/33329598/ |
| Author | Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. |
Licensing
[edit]
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 20:41, 12 June 2024 | | 793 × 555 (146 KB) | Ozzie10aaaa (talk | contribs) | Uploaded a work by Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. from https://pubmed.ncbi.nlm.nih.gov/33329598/ with UploadWizard |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
